nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC10A2—bile duct—liver cancer	0.229	0.558	CbGeAlD
Valaciclovir—SLC10A2—bile—liver cancer	0.176	0.429	CbGeAlD
Valaciclovir—SLC10A2—Recycling of bile acids and salts—NR1H4—liver cancer	0.0261	0.108	CbGpPWpGaD
Valaciclovir—SLC10A2—Bile acid and bile salt metabolism—NR1H4—liver cancer	0.0136	0.0566	CbGpPWpGaD
Valaciclovir—Leukocytoclastic vasculitis—Sorafenib—liver cancer	0.0117	0.0337	CcSEcCtD
Valaciclovir—Rhinorrhoea—Sorafenib—liver cancer	0.00711	0.0204	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—DNAJB1—liver cancer	0.00696	0.0289	CbGpPWpGaD
Valaciclovir—SLC10A2—Recycling of bile acids and salts—ALB—liver cancer	0.00694	0.0288	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00652	0.0271	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00622	0.0258	CbGpPWpGaD
Valaciclovir—SLC10A2—Orphan transporters—ANXA2—liver cancer	0.00617	0.0256	CbGpPWpGaD
Valaciclovir—SLC10A2—Orphan transporters—NR1H4—liver cancer	0.00584	0.0242	CbGpPWpGaD
Valaciclovir—SLC15A1—liver—liver cancer	0.00556	0.0135	CbGeAlD
Valaciclovir—Mouth ulceration—Sorafenib—liver cancer	0.00521	0.0149	CcSEcCtD
Valaciclovir—Eczema—Sorafenib—liver cancer	0.00465	0.0133	CcSEcCtD
Valaciclovir—Renal failure acute—Sorafenib—liver cancer	0.00453	0.013	CcSEcCtD
Valaciclovir—Rectal disorder—Epirubicin—liver cancer	0.00434	0.0125	CcSEcCtD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—liver cancer	0.00428	0.0178	CbGpPWpGaD
Valaciclovir—Anorectal disorder—Epirubicin—liver cancer	0.00405	0.0116	CcSEcCtD
Valaciclovir—Rectal disorder—Doxorubicin—liver cancer	0.00402	0.0115	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—GSTA3—liver cancer	0.004	0.0166	CbGpPWpGaD
Valaciclovir—Dehydration—Sorafenib—liver cancer	0.00389	0.0112	CcSEcCtD
Valaciclovir—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00376	0.0108	CcSEcCtD
Valaciclovir—Anorectal disorder—Doxorubicin—liver cancer	0.00375	0.0107	CcSEcCtD
Valaciclovir—Nasopharyngitis—Sorafenib—liver cancer	0.00374	0.0107	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00369	0.0106	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—GSTA4—liver cancer	0.00366	0.0152	CbGpPWpGaD
Valaciclovir—SLC10A2—Bile acid and bile salt metabolism—ALB—liver cancer	0.00363	0.0151	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTA2—liver cancer	0.00357	0.0148	CbGpPWpGaD
Valaciclovir—Abdominal discomfort—Sorafenib—liver cancer	0.00346	0.00994	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—GSTA1—liver cancer	0.00344	0.0143	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00322	0.0134	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00322	0.0134	CbGpPWpGaD
Valaciclovir—Renal failure—Sorafenib—liver cancer	0.00317	0.00909	CcSEcCtD
Valaciclovir—Stomatitis—Sorafenib—liver cancer	0.00314	0.00901	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Sorafenib—liver cancer	0.00305	0.00874	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—NFE2L2—liver cancer	0.00303	0.0126	CbGpPWpGaD
Valaciclovir—SLC10A2—Orphan transporters—CYCS—liver cancer	0.00297	0.0124	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00296	0.0123	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00294	0.0122	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00294	0.0122	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GPX3—liver cancer	0.00289	0.012	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—TGFA—liver cancer	0.00289	0.012	CbGpPWpGaD
Valaciclovir—Urinary tract disorder—Sorafenib—liver cancer	0.00286	0.0082	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—SERPINA1—liver cancer	0.00285	0.0118	CbGpPWpGaD
Valaciclovir—Urethral disorder—Sorafenib—liver cancer	0.00284	0.00814	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00283	0.0117	CbGpPWpGaD
Valaciclovir—Erythema multiforme—Sorafenib—liver cancer	0.00273	0.00785	CcSEcCtD
Valaciclovir—Immune system disorder—Sorafenib—liver cancer	0.00261	0.0075	CcSEcCtD
Valaciclovir—Mediastinal disorder—Sorafenib—liver cancer	0.00261	0.00748	CcSEcCtD
Valaciclovir—Alopecia—Sorafenib—liver cancer	0.00256	0.00733	CcSEcCtD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00255	0.0106	CbGpPWpGaD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00243	0.0101	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00241	0.01	CbGpPWpGaD
Valaciclovir—Anaemia—Sorafenib—liver cancer	0.00233	0.00668	CcSEcCtD
Valaciclovir—Cough increased—Epirubicin—liver cancer	0.00232	0.00667	CcSEcCtD
Valaciclovir—Herpes simplex—Epirubicin—liver cancer	0.00231	0.00663	CcSEcCtD
Valaciclovir—Angioedema—Sorafenib—liver cancer	0.0023	0.0066	CcSEcCtD
Valaciclovir—Leukopenia—Sorafenib—liver cancer	0.00225	0.00647	CcSEcCtD
Valaciclovir—Dysarthria—Epirubicin—liver cancer	0.00225	0.00646	CcSEcCtD
Valaciclovir—Creatinine increased—Epirubicin—liver cancer	0.00224	0.00642	CcSEcCtD
Valaciclovir—Cough—Sorafenib—liver cancer	0.0022	0.0063	CcSEcCtD
Valaciclovir—Hypertension—Sorafenib—liver cancer	0.00217	0.00624	CcSEcCtD
Valaciclovir—Cough increased—Doxorubicin—liver cancer	0.00215	0.00617	CcSEcCtD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.00215	0.00892	CbGpPWpGaD
Valaciclovir—Myalgia—Sorafenib—liver cancer	0.00214	0.00615	CcSEcCtD
Valaciclovir—Arthralgia—Sorafenib—liver cancer	0.00214	0.00615	CcSEcCtD
Valaciclovir—Herpes simplex—Doxorubicin—liver cancer	0.00214	0.00613	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00213	0.00611	CcSEcCtD
Valaciclovir—Phosphatase alkaline increased—Epirubicin—liver cancer	0.00213	0.00611	CcSEcCtD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00213	0.00883	CbGpPWpGaD
Valaciclovir—Dry mouth—Sorafenib—liver cancer	0.0021	0.00602	CcSEcCtD
Valaciclovir—SLC10A2—Orphan transporters—PPARA—liver cancer	0.00209	0.00867	CbGpPWpGaD
Valaciclovir—Dysarthria—Doxorubicin—liver cancer	0.00208	0.00598	CcSEcCtD
Valaciclovir—Creatinine increased—Doxorubicin—liver cancer	0.00207	0.00594	CcSEcCtD
Valaciclovir—Anaphylactic shock—Sorafenib—liver cancer	0.00205	0.0059	CcSEcCtD
Valaciclovir—Infection—Sorafenib—liver cancer	0.00204	0.00586	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—GGT1—liver cancer	0.00203	0.00845	CbGpPWpGaD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00203	0.00842	CbGpPWpGaD
Valaciclovir—Nervous system disorder—Sorafenib—liver cancer	0.00202	0.00578	CcSEcCtD
Valaciclovir—Thrombocytopenia—Sorafenib—liver cancer	0.00201	0.00577	CcSEcCtD
Valaciclovir—Aplastic anaemia—Epirubicin—liver cancer	0.002	0.00573	CcSEcCtD
Valaciclovir—Skin disorder—Sorafenib—liver cancer	0.002	0.00573	CcSEcCtD
Valaciclovir—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.00197	0.00565	CcSEcCtD
Valaciclovir—Anorexia—Sorafenib—liver cancer	0.00196	0.00562	CcSEcCtD
Valaciclovir—Coma—Epirubicin—liver cancer	0.00194	0.00558	CcSEcCtD
Valaciclovir—Mouth ulceration—Epirubicin—liver cancer	0.00192	0.00552	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00187	0.00537	CcSEcCtD
Valaciclovir—Aplastic anaemia—Doxorubicin—liver cancer	0.00185	0.00531	CcSEcCtD
Valaciclovir—Dyspnoea—Sorafenib—liver cancer	0.00183	0.00526	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—GSTP1—liver cancer	0.00183	0.00759	CbGpPWpGaD
Valaciclovir—Dyspepsia—Sorafenib—liver cancer	0.00181	0.00519	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—HMOX1—liver cancer	0.0018	0.00749	CbGpPWpGaD
Valaciclovir—Coma—Doxorubicin—liver cancer	0.0018	0.00516	CcSEcCtD
Valaciclovir—Decreased appetite—Sorafenib—liver cancer	0.00179	0.00513	CcSEcCtD
Valaciclovir—Mouth ulceration—Doxorubicin—liver cancer	0.00178	0.00511	CcSEcCtD
Valaciclovir—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00178	0.0051	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Sorafenib—liver cancer	0.00177	0.00509	CcSEcCtD
Valaciclovir—Fatigue—Sorafenib—liver cancer	0.00177	0.00508	CcSEcCtD
Valaciclovir—Photosensitivity—Epirubicin—liver cancer	0.00176	0.00505	CcSEcCtD
Valaciclovir—Pain—Sorafenib—liver cancer	0.00176	0.00504	CcSEcCtD
Valaciclovir—Constipation—Sorafenib—liver cancer	0.00176	0.00504	CcSEcCtD
Valaciclovir—Eczema—Epirubicin—liver cancer	0.00172	0.00493	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Sorafenib—liver cancer	0.00168	0.00482	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—HGF—liver cancer	0.00168	0.00697	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTM1—liver cancer	0.00168	0.00697	CbGpPWpGaD
Valaciclovir—Renal failure acute—Epirubicin—liver cancer	0.00167	0.0048	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00165	0.00684	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	0.00164	0.00683	CbGpPWpGaD
Valaciclovir—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00164	0.00472	CcSEcCtD
Valaciclovir—Urticaria—Sorafenib—liver cancer	0.00163	0.00468	CcSEcCtD
Valaciclovir—Photosensitivity—Doxorubicin—liver cancer	0.00163	0.00467	CcSEcCtD
Valaciclovir—Body temperature increased—Sorafenib—liver cancer	0.00162	0.00466	CcSEcCtD
Valaciclovir—Abdominal pain—Sorafenib—liver cancer	0.00162	0.00466	CcSEcCtD
Valaciclovir—Renal impairment—Epirubicin—liver cancer	0.00162	0.00466	CcSEcCtD
Valaciclovir—Eczema—Doxorubicin—liver cancer	0.00159	0.00456	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00157	0.00652	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00155	0.00645	CbGpPWpGaD
Valaciclovir—Renal failure acute—Doxorubicin—liver cancer	0.00155	0.00444	CcSEcCtD
Valaciclovir—Osteoarthritis—Epirubicin—liver cancer	0.00155	0.00443	CcSEcCtD
Valaciclovir—Migraine—Epirubicin—liver cancer	0.00152	0.00436	CcSEcCtD
Valaciclovir—Hypersensitivity—Sorafenib—liver cancer	0.00151	0.00434	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00151	0.00626	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00151	0.00626	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00151	0.00626	CbGpPWpGaD
Valaciclovir—Renal impairment—Doxorubicin—liver cancer	0.0015	0.00431	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.0015	0.00622	CbGpPWpGaD
Valaciclovir—Face oedema—Epirubicin—liver cancer	0.00149	0.00428	CcSEcCtD
Valaciclovir—Asthenia—Sorafenib—liver cancer	0.00147	0.00423	CcSEcCtD
Valaciclovir—Pruritus—Sorafenib—liver cancer	0.00145	0.00417	CcSEcCtD
Valaciclovir—Ataxia—Epirubicin—liver cancer	0.00145	0.00417	CcSEcCtD
Valaciclovir—Blood creatinine increased—Epirubicin—liver cancer	0.00145	0.00415	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00144	0.00597	CbGpPWpGaD
Valaciclovir—Dehydration—Epirubicin—liver cancer	0.00144	0.00412	CcSEcCtD
Valaciclovir—Osteoarthritis—Doxorubicin—liver cancer	0.00143	0.0041	CcSEcCtD
Valaciclovir—Liver function test abnormal—Epirubicin—liver cancer	0.00143	0.00409	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00142	0.00592	CbGpPWpGaD
Valaciclovir—Migraine—Doxorubicin—liver cancer	0.00141	0.00404	CcSEcCtD
Valaciclovir—Diarrhoea—Sorafenib—liver cancer	0.00141	0.00403	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.0014	0.00582	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00139	0.00578	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00139	0.00578	CbGpPWpGaD
Valaciclovir—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00139	0.00399	CcSEcCtD
Valaciclovir—Nasopharyngitis—Epirubicin—liver cancer	0.00138	0.00396	CcSEcCtD
Valaciclovir—Face oedema—Doxorubicin—liver cancer	0.00138	0.00396	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00138	0.00572	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00138	0.00572	CbGpPWpGaD
Valaciclovir—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00136	0.00391	CcSEcCtD
Valaciclovir—Dizziness—Sorafenib—liver cancer	0.00136	0.0039	CcSEcCtD
Valaciclovir—Ataxia—Doxorubicin—liver cancer	0.00134	0.00386	CcSEcCtD
Valaciclovir—Blood creatinine increased—Doxorubicin—liver cancer	0.00134	0.00384	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00134	0.00555	CbGpPWpGaD
Valaciclovir—Influenza—Epirubicin—liver cancer	0.00134	0.00383	CcSEcCtD
Valaciclovir—Dehydration—Doxorubicin—liver cancer	0.00133	0.00382	CcSEcCtD
Valaciclovir—Liver function test abnormal—Doxorubicin—liver cancer	0.00132	0.00379	CcSEcCtD
Valaciclovir—Vomiting—Sorafenib—liver cancer	0.00131	0.00375	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—NR1H4—liver cancer	0.0013	0.00541	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.0013	0.0054	CbGpPWpGaD
Valaciclovir—Rash—Sorafenib—liver cancer	0.0013	0.00372	CcSEcCtD
Valaciclovir—Dermatitis—Sorafenib—liver cancer	0.00129	0.00371	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00129	0.00536	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00129	0.00536	CbGpPWpGaD
Valaciclovir—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00129	0.00369	CcSEcCtD
Valaciclovir—Headache—Sorafenib—liver cancer	0.00129	0.00369	CcSEcCtD
Valaciclovir—Bronchitis—Epirubicin—liver cancer	0.00128	0.00369	CcSEcCtD
Valaciclovir—Nasopharyngitis—Doxorubicin—liver cancer	0.00128	0.00367	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00126	0.00362	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00124	0.00516	CbGpPWpGaD
Valaciclovir—Upper respiratory tract infection—Epirubicin—liver cancer	0.00124	0.00356	CcSEcCtD
Valaciclovir—Influenza—Doxorubicin—liver cancer	0.00124	0.00355	CcSEcCtD
Valaciclovir—Nausea—Sorafenib—liver cancer	0.00122	0.0035	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Epirubicin—liver cancer	0.00122	0.0035	CcSEcCtD
Valaciclovir—Bronchitis—Doxorubicin—liver cancer	0.00119	0.00341	CcSEcCtD
Valaciclovir—Renal failure—Epirubicin—liver cancer	0.00117	0.00336	CcSEcCtD
Valaciclovir—Stomatitis—Epirubicin—liver cancer	0.00116	0.00333	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00116	0.00481	CbGpPWpGaD
Valaciclovir—Urinary tract infection—Epirubicin—liver cancer	0.00116	0.00332	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00115	0.00477	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00115	0.00477	CbGpPWpGaD
Valaciclovir—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00115	0.0033	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00115	0.00476	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—UGDH—liver cancer	0.00114	0.00474	CbGpPWpGaD
Valaciclovir—Haematuria—Epirubicin—liver cancer	0.00114	0.00326	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Doxorubicin—liver cancer	0.00113	0.00324	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Epirubicin—liver cancer	0.00113	0.00323	CcSEcCtD
Valaciclovir—Sinusitis—Epirubicin—liver cancer	0.00112	0.00321	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.0011	0.00459	CbGpPWpGaD
Valaciclovir—Renal failure—Doxorubicin—liver cancer	0.00108	0.00311	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—EPT1—liver cancer	0.00107	0.00446	CbGpPWpGaD
Valaciclovir—Stomatitis—Doxorubicin—liver cancer	0.00107	0.00308	CcSEcCtD
Valaciclovir—Rhinitis—Epirubicin—liver cancer	0.00107	0.00307	CcSEcCtD
Valaciclovir—Urinary tract infection—Doxorubicin—liver cancer	0.00107	0.00307	CcSEcCtD
Valaciclovir—Hepatitis—Epirubicin—liver cancer	0.00107	0.00307	CcSEcCtD
Valaciclovir—Pharyngitis—Epirubicin—liver cancer	0.00106	0.00304	CcSEcCtD
Valaciclovir—Urinary tract disorder—Epirubicin—liver cancer	0.00106	0.00303	CcSEcCtD
Valaciclovir—Oedema peripheral—Epirubicin—liver cancer	0.00105	0.00302	CcSEcCtD
Valaciclovir—Haematuria—Doxorubicin—liver cancer	0.00105	0.00301	CcSEcCtD
Valaciclovir—Urethral disorder—Epirubicin—liver cancer	0.00105	0.00301	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Doxorubicin—liver cancer	0.00104	0.00299	CcSEcCtD
Valaciclovir—Sinusitis—Doxorubicin—liver cancer	0.00103	0.00297	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—TAT—liver cancer	0.00102	0.00423	CbGpPWpGaD
Valaciclovir—Erythema multiforme—Epirubicin—liver cancer	0.00101	0.0029	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.001	0.00416	CbGpPWpGaD
Valaciclovir—Rhinitis—Doxorubicin—liver cancer	0.000991	0.00285	CcSEcCtD
Valaciclovir—Hepatitis—Doxorubicin—liver cancer	0.000989	0.00284	CcSEcCtD
Valaciclovir—Pharyngitis—Doxorubicin—liver cancer	0.000982	0.00282	CcSEcCtD
Valaciclovir—Urinary tract disorder—Doxorubicin—liver cancer	0.000977	0.0028	CcSEcCtD
Valaciclovir—Oedema peripheral—Doxorubicin—liver cancer	0.000974	0.0028	CcSEcCtD
Valaciclovir—Urethral disorder—Doxorubicin—liver cancer	0.000969	0.00278	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000966	0.00401	CbGpPWpGaD
Valaciclovir—Immune system disorder—Epirubicin—liver cancer	0.000965	0.00277	CcSEcCtD
Valaciclovir—Mediastinal disorder—Epirubicin—liver cancer	0.000963	0.00276	CcSEcCtD
Valaciclovir—Chills—Epirubicin—liver cancer	0.000959	0.00275	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000959	0.00398	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000959	0.00398	CbGpPWpGaD
Valaciclovir—Alopecia—Epirubicin—liver cancer	0.000944	0.00271	CcSEcCtD
Valaciclovir—Erythema multiforme—Doxorubicin—liver cancer	0.000935	0.00268	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000922	0.00383	CbGpPWpGaD
Valaciclovir—Flatulence—Epirubicin—liver cancer	0.000917	0.00263	CcSEcCtD
Valaciclovir—Tension—Epirubicin—liver cancer	0.000913	0.00262	CcSEcCtD
Valaciclovir—Nervousness—Epirubicin—liver cancer	0.000904	0.00259	CcSEcCtD
Valaciclovir—Back pain—Epirubicin—liver cancer	0.0009	0.00258	CcSEcCtD
Valaciclovir—Immune system disorder—Doxorubicin—liver cancer	0.000893	0.00256	CcSEcCtD
Valaciclovir—Mediastinal disorder—Doxorubicin—liver cancer	0.000891	0.00256	CcSEcCtD
Valaciclovir—Chills—Doxorubicin—liver cancer	0.000887	0.00255	CcSEcCtD
Valaciclovir—Alopecia—Doxorubicin—liver cancer	0.000874	0.00251	CcSEcCtD
Valaciclovir—Anaemia—Epirubicin—liver cancer	0.00086	0.00247	CcSEcCtD
Valaciclovir—Agitation—Epirubicin—liver cancer	0.000855	0.00245	CcSEcCtD
Valaciclovir—Flatulence—Doxorubicin—liver cancer	0.000848	0.00243	CcSEcCtD
Valaciclovir—Tension—Doxorubicin—liver cancer	0.000845	0.00242	CcSEcCtD
Valaciclovir—Nervousness—Doxorubicin—liver cancer	0.000836	0.0024	CcSEcCtD
Valaciclovir—Leukopenia—Epirubicin—liver cancer	0.000833	0.00239	CcSEcCtD
Valaciclovir—Back pain—Doxorubicin—liver cancer	0.000833	0.00239	CcSEcCtD
Valaciclovir—Cough—Epirubicin—liver cancer	0.000812	0.00233	CcSEcCtD
Valaciclovir—Convulsion—Epirubicin—liver cancer	0.000806	0.00231	CcSEcCtD
Valaciclovir—Hypertension—Epirubicin—liver cancer	0.000803	0.00231	CcSEcCtD
Valaciclovir—Anaemia—Doxorubicin—liver cancer	0.000796	0.00228	CcSEcCtD
Valaciclovir—Arthralgia—Epirubicin—liver cancer	0.000792	0.00227	CcSEcCtD
Valaciclovir—Chest pain—Epirubicin—liver cancer	0.000792	0.00227	CcSEcCtD
Valaciclovir—Myalgia—Epirubicin—liver cancer	0.000792	0.00227	CcSEcCtD
Valaciclovir—Agitation—Doxorubicin—liver cancer	0.000791	0.00227	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000787	0.00226	CcSEcCtD
Valaciclovir—Dry mouth—Epirubicin—liver cancer	0.000775	0.00222	CcSEcCtD
Valaciclovir—Leukopenia—Doxorubicin—liver cancer	0.000771	0.00221	CcSEcCtD
Valaciclovir—Confusional state—Epirubicin—liver cancer	0.000766	0.0022	CcSEcCtD
Valaciclovir—Oedema—Epirubicin—liver cancer	0.000759	0.00218	CcSEcCtD
Valaciclovir—Anaphylactic shock—Epirubicin—liver cancer	0.000759	0.00218	CcSEcCtD
Valaciclovir—Infection—Epirubicin—liver cancer	0.000754	0.00216	CcSEcCtD
Valaciclovir—Cough—Doxorubicin—liver cancer	0.000751	0.00216	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000749	0.00311	CbGpPWpGaD
Valaciclovir—Convulsion—Doxorubicin—liver cancer	0.000746	0.00214	CcSEcCtD
Valaciclovir—Nervous system disorder—Epirubicin—liver cancer	0.000745	0.00214	CcSEcCtD
Valaciclovir—Thrombocytopenia—Epirubicin—liver cancer	0.000743	0.00213	CcSEcCtD
Valaciclovir—Hypertension—Doxorubicin—liver cancer	0.000743	0.00213	CcSEcCtD
Valaciclovir—Tachycardia—Epirubicin—liver cancer	0.000741	0.00213	CcSEcCtD
Valaciclovir—Skin disorder—Epirubicin—liver cancer	0.000738	0.00212	CcSEcCtD
Valaciclovir—Arthralgia—Doxorubicin—liver cancer	0.000733	0.0021	CcSEcCtD
Valaciclovir—Chest pain—Doxorubicin—liver cancer	0.000733	0.0021	CcSEcCtD
Valaciclovir—Myalgia—Doxorubicin—liver cancer	0.000733	0.0021	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000728	0.00209	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000726	0.00302	CbGpPWpGaD
Valaciclovir—Anorexia—Epirubicin—liver cancer	0.000724	0.00208	CcSEcCtD
Valaciclovir—Dry mouth—Doxorubicin—liver cancer	0.000717	0.00206	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000713	0.00296	CbGpPWpGaD
Valaciclovir—Confusional state—Doxorubicin—liver cancer	0.000708	0.00203	CcSEcCtD
Valaciclovir—Anaphylactic shock—Doxorubicin—liver cancer	0.000703	0.00202	CcSEcCtD
Valaciclovir—Oedema—Doxorubicin—liver cancer	0.000703	0.00202	CcSEcCtD
Valaciclovir—Infection—Doxorubicin—liver cancer	0.000698	0.002	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CPT1B—liver cancer	0.000692	0.00287	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GLUL—liver cancer	0.000692	0.00287	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000692	0.00199	CcSEcCtD
Valaciclovir—Nervous system disorder—Doxorubicin—liver cancer	0.000689	0.00198	CcSEcCtD
Valaciclovir—Thrombocytopenia—Doxorubicin—liver cancer	0.000688	0.00197	CcSEcCtD
Valaciclovir—Insomnia—Epirubicin—liver cancer	0.000687	0.00197	CcSEcCtD
Valaciclovir—Tachycardia—Doxorubicin—liver cancer	0.000686	0.00197	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—TGFB1—liver cancer	0.000685	0.00284	CbGpPWpGaD
Valaciclovir—Skin disorder—Doxorubicin—liver cancer	0.000682	0.00196	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—liver cancer	0.000682	0.00283	CbGpPWpGaD
Valaciclovir—Paraesthesia—Epirubicin—liver cancer	0.000682	0.00196	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00068	0.00282	CbGpPWpGaD
Valaciclovir—Dyspnoea—Epirubicin—liver cancer	0.000677	0.00194	CcSEcCtD
Valaciclovir—Somnolence—Epirubicin—liver cancer	0.000675	0.00194	CcSEcCtD
Valaciclovir—Anorexia—Doxorubicin—liver cancer	0.00067	0.00192	CcSEcCtD
Valaciclovir—Dyspepsia—Epirubicin—liver cancer	0.000668	0.00192	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NR1H4—liver cancer	0.000667	0.00277	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—CYCS—liver cancer	0.000664	0.00276	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000661	0.00275	CbGpPWpGaD
Valaciclovir—Decreased appetite—Epirubicin—liver cancer	0.00066	0.00189	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GSTA3—liver cancer	0.000656	0.00272	CbGpPWpGaD
Valaciclovir—Gastrointestinal disorder—Epirubicin—liver cancer	0.000656	0.00188	CcSEcCtD
Valaciclovir—Fatigue—Epirubicin—liver cancer	0.000655	0.00188	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000652	0.00271	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000652	0.00271	CbGpPWpGaD
Valaciclovir—Constipation—Epirubicin—liver cancer	0.000649	0.00186	CcSEcCtD
Valaciclovir—Pain—Epirubicin—liver cancer	0.000649	0.00186	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00064	0.00184	CcSEcCtD
Valaciclovir—Insomnia—Doxorubicin—liver cancer	0.000635	0.00182	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000631	0.00262	CbGpPWpGaD
Valaciclovir—Paraesthesia—Doxorubicin—liver cancer	0.000631	0.00181	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000631	0.00262	CbGpPWpGaD
Valaciclovir—Dyspnoea—Doxorubicin—liver cancer	0.000626	0.0018	CcSEcCtD
Valaciclovir—Feeling abnormal—Epirubicin—liver cancer	0.000626	0.0018	CcSEcCtD
Valaciclovir—Somnolence—Doxorubicin—liver cancer	0.000625	0.00179	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Epirubicin—liver cancer	0.000621	0.00178	CcSEcCtD
Valaciclovir—Dyspepsia—Doxorubicin—liver cancer	0.000618	0.00177	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000616	0.00256	CbGpPWpGaD
Valaciclovir—Decreased appetite—Doxorubicin—liver cancer	0.000611	0.00175	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000607	0.00174	CcSEcCtD
Valaciclovir—Fatigue—Doxorubicin—liver cancer	0.000606	0.00174	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000605	0.00251	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000605	0.00251	CbGpPWpGaD
Valaciclovir—Urticaria—Epirubicin—liver cancer	0.000603	0.00173	CcSEcCtD
Valaciclovir—Constipation—Doxorubicin—liver cancer	0.000601	0.00172	CcSEcCtD
Valaciclovir—Pain—Doxorubicin—liver cancer	0.000601	0.00172	CcSEcCtD
Valaciclovir—Abdominal pain—Epirubicin—liver cancer	0.0006	0.00172	CcSEcCtD
Valaciclovir—Body temperature increased—Epirubicin—liver cancer	0.0006	0.00172	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GSTA4—liver cancer	0.0006	0.00249	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000588	0.00244	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000586	0.00243	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA2—liver cancer	0.000585	0.00243	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Doxorubicin—liver cancer	0.000579	0.00166	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000577	0.0024	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Doxorubicin—liver cancer	0.000575	0.00165	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000572	0.00237	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA1—liver cancer	0.000564	0.00234	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000561	0.00233	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Epirubicin—liver cancer	0.000559	0.00161	CcSEcCtD
Valaciclovir—Urticaria—Doxorubicin—liver cancer	0.000558	0.0016	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NAT2—liver cancer	0.000558	0.00232	CbGpPWpGaD
Valaciclovir—Body temperature increased—Doxorubicin—liver cancer	0.000555	0.00159	CcSEcCtD
Valaciclovir—Abdominal pain—Doxorubicin—liver cancer	0.000555	0.00159	CcSEcCtD
Valaciclovir—Asthenia—Epirubicin—liver cancer	0.000545	0.00156	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000538	0.00223	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000538	0.00223	CbGpPWpGaD
Valaciclovir—Pruritus—Epirubicin—liver cancer	0.000537	0.00154	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000536	0.00223	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALDOB—liver cancer	0.000535	0.00222	CbGpPWpGaD
Valaciclovir—Diarrhoea—Epirubicin—liver cancer	0.00052	0.00149	CcSEcCtD
Valaciclovir—Hypersensitivity—Doxorubicin—liver cancer	0.000518	0.00149	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CRABP1—liver cancer	0.00051	0.00212	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—PPARA—liver cancer	0.00051	0.00212	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000509	0.00211	CbGpPWpGaD
Valaciclovir—Asthenia—Doxorubicin—liver cancer	0.000504	0.00145	CcSEcCtD
Valaciclovir—Dizziness—Epirubicin—liver cancer	0.000502	0.00144	CcSEcCtD
Valaciclovir—Pruritus—Doxorubicin—liver cancer	0.000497	0.00143	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000491	0.00204	CbGpPWpGaD
Valaciclovir—Vomiting—Epirubicin—liver cancer	0.000483	0.00139	CcSEcCtD
Valaciclovir—Diarrhoea—Doxorubicin—liver cancer	0.000481	0.00138	CcSEcCtD
Valaciclovir—Rash—Epirubicin—liver cancer	0.000479	0.00137	CcSEcCtD
Valaciclovir—Dermatitis—Epirubicin—liver cancer	0.000478	0.00137	CcSEcCtD
Valaciclovir—Headache—Epirubicin—liver cancer	0.000476	0.00137	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000468	0.00194	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—PPARA—liver cancer	0.000466	0.00194	CbGpPWpGaD
Valaciclovir—Dizziness—Doxorubicin—liver cancer	0.000465	0.00133	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000459	0.00191	CbGpPWpGaD
Valaciclovir—Nausea—Epirubicin—liver cancer	0.000451	0.00129	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000449	0.00186	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000449	0.00186	CbGpPWpGaD
Valaciclovir—Vomiting—Doxorubicin—liver cancer	0.000447	0.00128	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—HPGDS—liver cancer	0.000446	0.00185	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000443	0.00184	CbGpPWpGaD
Valaciclovir—Rash—Doxorubicin—liver cancer	0.000443	0.00127	CcSEcCtD
Valaciclovir—Dermatitis—Doxorubicin—liver cancer	0.000443	0.00127	CcSEcCtD
Valaciclovir—Headache—Doxorubicin—liver cancer	0.00044	0.00126	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000425	0.00176	CbGpPWpGaD
Valaciclovir—Nausea—Doxorubicin—liver cancer	0.000417	0.0012	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000404	0.00168	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000399	0.00166	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PSMD10—liver cancer	0.000397	0.00165	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PSMA4—liver cancer	0.000397	0.00165	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GOT2—liver cancer	0.000387	0.00161	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—liver cancer	0.000379	0.00157	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP2E1—liver cancer	0.000364	0.00151	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000352	0.00146	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—liver cancer	0.000347	0.00144	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000343	0.00142	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYCS—liver cancer	0.00034	0.00141	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GGT1—liver cancer	0.000334	0.00139	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GOT1—liver cancer	0.000334	0.00139	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—liver cancer	0.000323	0.00134	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000314	0.0013	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—RAF1—liver cancer	0.000314	0.0013	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTP1—liver cancer	0.0003	0.00124	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.000299	0.00124	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HMOX1—liver cancer	0.000296	0.00123	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000292	0.00121	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTM1—liver cancer	0.000275	0.00114	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000273	0.00113	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—liver cancer	0.000266	0.00111	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP1A1—liver cancer	0.000261	0.00108	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—CYCS—liver cancer	0.000259	0.00108	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000253	0.00105	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MTHFR—liver cancer	0.000243	0.00101	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPARA—liver cancer	0.000239	0.000992	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000225	0.000936	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	0.000222	0.000923	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000221	0.000916	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	0.000216	0.000899	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000215	0.000891	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000205	0.00085	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CG—liver cancer	0.000205	0.000849	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPARG—liver cancer	0.000197	0.00082	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000188	0.000781	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—PPARA—liver cancer	0.000182	0.000756	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CD—liver cancer	0.00018	0.000747	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALB—liver cancer	0.000178	0.000737	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—liver cancer	0.000164	0.000681	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CB—liver cancer	0.000157	0.000651	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000152	0.000632	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	0.000152	0.000631	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000148	0.000616	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000138	0.000571	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—liver cancer	0.000135	0.000562	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—RAF1—liver cancer	0.000122	0.000508	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	0.000113	0.000469	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	0.000102	0.000424	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CA—liver cancer	9.56e-05	0.000397	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AKT1—liver cancer	7.81e-05	0.000324	CbGpPWpGaD
